SABCS 2022 | Highlights from the San Antonio Breast Cancer Symposium 2022

Virginia Kaklamani, MD, UT Southwestern Medical Center, Dallas, TX, shares her highlights from the San Antonio Breast Cancer Symposium (SABCS) 2022, including data on endocrine-sensitive tumors and ER-positive breast cancer, a HER2 session on antibody-drug conjugates (ADCs) on HER2-positive and HER2-low disease and a session on oral SERDs and AKT inhibitors in ER-positive disease. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) 2022 in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.